Transcriptional Regulation of Fibroblast Growth Factor 21 Expression

Fibroblast growth factor 21 (FGF21) is an attractive target for treating metabolic disease due to its wide-ranging beneficial effects on glucose and lipid metabolism. Circulating FGF21 levels are increased in insulin-resistant states; however, endogenous FGF21 fails to improve glucose and lipid meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Kwi-Hyun, Kim, Jung-Guk, Park, Keun-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091486/
https://www.ncbi.nlm.nih.gov/pubmed/25031882
http://dx.doi.org/10.3803/EnM.2014.29.2.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091486/
https://www.ncbi.nlm.nih.gov/pubmed/25031882
http://dx.doi.org/10.3803/EnM.2014.29.2.105

Ejemplares similares